Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis

[1]  A. Horwitz,et al.  BRCA1 represses amphiregulin gene expression. , 2010, Cancer research.

[2]  Jing Fang,et al.  Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. , 2010, Gastroenterology.

[3]  C. Holterman,et al.  Human cancers converge at the HIF-2α oncogenic axis , 2009, Proceedings of the National Academy of Sciences.

[4]  William C Hahn,et al.  Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase. , 2009, Cancer cell.

[5]  H. Moch,et al.  Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response , 2009, Oncogene.

[6]  Howard Y. Chang,et al.  Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. , 2009, Cancer cell.

[7]  Frederik De Smet,et al.  Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization , 2009, Cell.

[8]  P. Bedossa,et al.  Overexpression of the Oxygen Sensors PHD-1, PHD-2, PHD-3, and FIH Is Associated with Tumor Aggressiveness in Pancreatic Endocrine Tumors , 2008, Clinical Cancer Research.

[9]  K. Miyazono,et al.  Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  M. Kiupel,et al.  The Biphasic Role of the Hypoxia-Inducible Factor Prolyl-4-Hydroxylase, PHD2, in Modulating Tumor-Forming Potential , 2008, Molecular Cancer Research.

[11]  S. Ethier,et al.  Amphiregulin as a Novel Target for Breast Cancer Therapy , 2008, Journal of Mammary Gland Biology and Neoplasia.

[12]  J. Howlin,et al.  Amphiregulin: Role in Mammary Gland Development and Breast Cancer , 2008, Journal of Mammary Gland Biology and Neoplasia.

[13]  F. Soncin,et al.  HIF-2α specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites , 2007, Oncogene.

[14]  K. Takeda,et al.  Essential Role for Prolyl Hydroxylase Domain Protein 2 in Oxygen Homeostasis of the Adult Vascular System , 2007, Circulation.

[15]  D. Jäger,et al.  NY‐ESO‐1 protein expression in primary breast carcinoma and metastases—correlation with CD8+ T‐cell and CD79a+ plasmacytic/B‐cell infiltration , 2007, International journal of cancer.

[16]  P. Hasgall,et al.  The Peptidyl Prolyl cis/trans Isomerase FKBP38 Determines Hypoxia-Inducible Transcription Factor Prolyl-4-Hydroxylase PHD2 Protein Stability , 2007, Molecular and Cellular Biology.

[17]  Roland H Wenger,et al.  Increased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels , 2006, Journal of Biological Chemistry.

[18]  J. Pouysségur,et al.  Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.

[19]  H. Mitsuhashi,et al.  Metalloprotease-dependent amphiregulin release mediates tumor necrosis factor-alpha-induced IL-8 secretion in the human airway epithelial cell line NCI-H292. , 2006, Life sciences.

[20]  N. Wake,et al.  Induction of human endometrial cancer cell senescence through modulation of HIF‐1α activity by EGLN1 , 2006, International journal of cancer.

[21]  P. Kronqvist,et al.  Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  M. Leonard,et al.  Hypoxia induces epithelial amphiregulin gene expression in a CREB-dependent manner. , 2006, American journal of physiology. Cell physiology.

[23]  G. Camenisch,et al.  Integration of Oxygen Signaling at the Consensus HRE , 2005, Science's STKE.

[24]  W. Kaelin,et al.  Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. , 2005, Cancer cell.

[25]  W. Jelkmann,et al.  Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. , 2005, The Biochemical journal.

[26]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[27]  F. Walther,et al.  Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. , 2004, Free radical biology & medicine.

[28]  Varda Rotter,et al.  Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth. , 2003, Cancer research.

[29]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[30]  pierre-Marie Martin,et al.  Transforming growth factor β‐1 and amphiregulin act in synergy to increase the production of urokinase‐type plasminogen activator in transformed breast epithelial cells , 2003 .

[31]  K. Eckardt,et al.  Activation of the hypoxia‐inducible factor pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  Mircea Ivan,et al.  Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Wenger,et al.  Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  S. McKnight,et al.  A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.

[35]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[36]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[37]  G. Semenza,et al.  Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. , 2001, Cancer research.

[38]  M. Gassmann,et al.  Epolones induce erythropoietin expression via hypoxia-inducible factor-1α activation , 2000 .

[39]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.

[40]  G. Millot,et al.  Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line , 1999, Oncogene.

[41]  W. Gerald,et al.  The Wilms Tumor Suppressor WT1 Encodes a Transcriptional Activator of amphiregulin , 1999, Cell.

[42]  David C. Lee,et al.  Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. , 1999, Development.

[43]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[44]  M. Gassmann,et al.  General applicability of chicken egg yolk antibodies: the performance of IgY immunoglobulins raised against the hypoxia‐inducible factor 1α , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  A. Harris,et al.  Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. , 1998, Blood.

[46]  M. Merino,et al.  Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues , 1996, International journal of cancer.

[47]  N. Normanno,et al.  Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines. , 1995, Endocrinology.

[48]  R. Coffey,et al.  Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family. , 1994, The Journal of biological chemistry.

[49]  G. Merlo,et al.  Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. , 1994, British Journal of Cancer.

[50]  I. Ellis,et al.  Method for grading breast cancer. , 1993, Journal of clinical pathology.

[51]  C. Disteche,et al.  The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity , 1990, Molecular and cellular biology.

[52]  G. Todaro,et al.  Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[53]  pierre-Marie Martin,et al.  Transforming growth factor beta-1 and amphiregulin act in synergy to increase the production of urokinase-type plasminogen activator in transformed breast epithelial cells. , 2003, International journal of cancer.